<DOC>
	<DOC>NCT00120237</DOC>
	<brief_summary>This community-based trial will study misoprostol for the prevention of postpartum hemorrhage in rural Pakistan. Traditional birth attendants assisting home deliveries will administer study tablets (600 mcg oral misoprostol or placebo) in the third stage of labor to women participating in the trial. Blood loss, hemoglobin levels, side effects, and other variables will be evaluated.</brief_summary>
	<brief_title>Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Pregnant women in general good health, home delivery Must live in one of 78 study villages Hypertension Noncephalic presentation Polyhydramnios Previous cesarean section Suspected multiple pregnancy Suspected still birth Antepartum hemorrhage Previous complication in 3rd trimester Anemia of &lt;8 g/dl</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Postpartum hemorrhage</keyword>
	<keyword>Misoprostol</keyword>
	<keyword>Maternal morbidity</keyword>
	<keyword>Developing countries</keyword>
	<keyword>Traditional birth attendants</keyword>
</DOC>